Clinical features of a severe asthma population eligible for biologics: a real life study
S. Garino (Turin, Italy), E. Riccardi (Turin, Italy), A. Sprio (Turin, Italy), F. Giannoccaro (Turin, Italy), A. Baroso (Turin, Italy), S. Pizzimenti (Turin, Italy), F. Ricciardolo (Turin, Italy)
Source: International Congress 2022 – Alpha-1 antitrypsin deficiency and chronic airway obstructive diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Garino (Turin, Italy), E. Riccardi (Turin, Italy), A. Sprio (Turin, Italy), F. Giannoccaro (Turin, Italy), A. Baroso (Turin, Italy), S. Pizzimenti (Turin, Italy), F. Ricciardolo (Turin, Italy). Clinical features of a severe asthma population eligible for biologics: a real life study. 2436
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|